LEMAITRE VASCULAR INC
For the period ended Aug 5, 2025. Filed Aug 5, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 5, 2025 · Filed Aug 5, 2025
Use the contents to explore the available documents and sections.
LMAT$80.89-3.1%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Share Repurchase Program
Share Repurchase Program
On February 18, 2025, the Company's Board of Directors authorized the repurchase of up to $75.0mm of the Company’s common stock. The repurchase program may be suspended or discontinued at any time and will conclude on February 17, 2026, unless extended by the Board.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.